Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIQUID - Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent, A Non-interventional, Observational, Prospective and Multi-center Study

NCT03524976 is registered in ClinicalTrials.gov with Dr. Markus Alfred Möhlenbruch as lead sponsor.

NCT NCT03524976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIQUID - Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent, A Non-interventional, Observational, Prospective and Multi-center Study
Lead sponsor
Dr. Markus Alfred Möhlenbruch
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
August 29, 2020
Enrollment
50 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

dural arteriovenous fistula